Michael Wheatcroft
- Molecular Biology
- Pharmacology top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Organic Chemistry
- Biotechnology top 10%
- Co-authors
- Peter F. LeadlayDaniel NietlispachKira J. WeissmanR. William BroadhurstTatiana MironenkoInes BöhmJames StauntonGabriele Wirtz
- Topics
- Radiopharmaceutical Chemistry and Applications (13 papers)Enzyme function and inhibition (4 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Michael Wheatcroft
14 papers receiving 493 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 314
- Pharmacology 270
- Radiology, Nuclear Medicine and Imaging 130
- Organic Chemistry 104
- Biotechnology 70
Countries citing papers authored by Michael Wheatcroft
This map shows the geographic impact of Michael Wheatcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wheatcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wheatcroft more than expected).
Fields of papers citing papers by Michael Wheatcroft
This network shows the impact of papers produced by Michael Wheatcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wheatcroft. The network helps show where Michael Wheatcroft may publish in the future.
Co-authorship network of co-authors of Michael Wheatcroft
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wheatcroft. A scholar is included among the top collaborators of Michael Wheatcroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wheatcroft. Michael Wheatcroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 16 | |
| 7 | 8 | |
| 8 | 1 | |
| 9 | 16 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 67 | |
| 13 | 4 | |
| 14 | 35 | |
| 15 | 169 | |
| 16 | Increasing the efficiency of heterologous promoters in actinomycetes. | 171 |
About Michael Wheatcroft
Michael Wheatcroft is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmaceutical Science and Biotechnology, having authored 16 papers that have together received 500 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (13 papers), Enzyme function and inhibition (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pharmacology (270 citations), Biotechnology (70 citations) and Radiology, Nuclear Medicine and Imaging (130 citations). Michael Wheatcroft has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Peter F. Leadlay, Daniel Nietlispach, Kira J. Weissman, R. William Broadhurst, Tatiana Mironenko, Ines Böhm, James Staunton, Gabriele Wirtz, Christine Martin and Christopher J. Wilkinson. Their work appears in journals such as Journal of Medicinal Chemistry, Chemical Science and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.